BRIEF PRESENTATION OF FINDINGS
- Pedro Kremer, Head of Impact Evaluation, Zipline
- Muhammad Ali Pate, Professor of the Practice of Public Health Leadership, Harvard School of Public Health, and Former Global Director, Health, Nutrition and Population (HNP) Global Practice of the World Bank
- James Maloney, Deputy Director, Global Health Bureau, USAID
- Emmanuel Ankrah Odame, Director of Policy Planning, Ministry of Health, Ghana
- Caitlin Burton, Vice President of Global Health Partnerships, Zipline
- Prashant Yadav, Senior Fellow, Center for Global Development
ABOUT THE EVENT
Well-functioning supply chains to deliver medicines, vaccines, and other health products are the backbone of the health system. Continued challenges in the financing, procurement, and distribution of health products lead to frequent stockouts at health clinics, putting treatment programs at risk and weakening overall health service delivery. Drones, or unmanned aerial vehicles (UAVs), are an innovative option for delivering health products, especially in regions where routine transport and distribution infrastructure remains weak. Drones are now starting to be utilized at national scale to transport health products including drugs, vaccines, blood, diagnostic specimens between health facilities, and PPE. There is lack of systematic evidence on the impact of drones for health product delivery at scale. As a result, country governments, global health agencies, and global life sciences companies question the feasibility and cost-effectiveness of drone based delivery in the health sector. Zipline is a provider of drone-based supply chain solutions to health systems in Rwanda, Ghana, and the United States. In their operations in Ghana, which started in 2018, they included a strong impact evaluation component to help find answers to some of these questions. This event, co-hosted with INSEAD-HRG, will start with a presentation of the results of the impact evaluation, followed by a panel discussion with senior health system leaders to discuss the implications of these findings.
if you have qestions for our panelists, please submit them to email@example.com, tweet @CGDev #CGDTalks, or submit your comments via YouTube.